Brighton Rehab and Wellness Responds to DOH Saying They Used Experimental Treatment with out Permission

(Brighton Twp.,Pa.) In response to the State of Pennsylvania stating in a release that Brighton Rehab and Wellness Center used an experimental treatment on residents who had the COVID-19 Brighton Rehab and Wellness said in a release that they  issued a plan of correction on July 7, 2020  to the PA Department of Health. The release states that their plan of correction is prepared and executed  to continuously  improve the quality of care and comply with all state and federal regulatory requirements.  Brighton Rehab and Wellness  can not  receive retroactive written approval  from the PA DOH   for the use of hydroxychloroquine in conjunction with zinc. The facility, according to the response  is no longer administering the drug to medically cleared patients with confirmed consent.

The PADOH will educate the medical director  and clinical leadership on resident’s rights  related to experimental research.

A consultant pharmacist/designee will perform random audits weekly for 4 weeks  thereafter  to assure hydroxychloroquine  in conjunction with zinc is not prescribed.